AbbVie : ABBV

All AbbVie Articles

579 Articles

Chris Lange | Mar 22, 2018 at 4:08 PM EDT

Thursday’s Biggest Winners and Losers in the S&P 500

Thursday was an absolute disaster for the broad U.S. markets. There didn’t seem to be anything positive about Thursday for…

Chris Lange | Mar 22, 2018 at 11:50 AM EDT

AbbVie Slides on Weak Midstage Results

AbbVie saw its shares pull back on Thursday after it reported less than favorable midstage results for its relapsed/refractory small…

Lee Jackson | Mar 19, 2018 at 10:05 AM EDT

Jefferies Adds Red-Hot Retail Stock to Franchise Picks List

Jefferies has made a big move by adding a top retail company to its well-respected Franchise Picks list of stocks…

Chris Lange | Mar 12, 2018 at 8:35 AM EDT

Major Pharma Sees Big Drop in Short Interest

The February 28 short interest data have been compared with the previous figures, and short interest in most of these…

Chris Lange | Feb 28, 2018 at 9:10 AM EST

Short Sellers Hike Bets in Major Pharma

The February 15 short interest data have been compared with the previous figures, and short interest in these selected pharmaceutical…

Lee Jackson | Feb 28, 2018 at 8:40 AM EST

Jefferies Has 5 Stocks to Buy That Should Raise Dividends and Earnings

These five stocks come with upward earnings revisions and the potential for rising dividends. They all make good sense for…

Jon C. Ogg | Feb 17, 2018 at 9:40 AM EST

13 Fresh Dividend Hikes and Stock Buybacks Too Big to Ignore

These were 13 stock buyback and dividend hike announcements from the week of February 16 that were simply too large…

Jon C. Ogg | Feb 15, 2018 at 1:20 PM EST

AbbVie Delivers on Promise of Higher Dividend and Stronger Stock Buybacks

AbbVie is joining the companies raising their shareholder rewards. The pharmaceutical products maker has announced how it will further commit…

Chris Lange | Feb 12, 2018 at 9:35 AM EST

Short Sellers Can’t Make Up Their Minds on Major Pharma

The January 31 short interest data have been compared with the previous figures, and short interest moves in these selected…

Lee Jackson | Feb 1, 2018 at 9:40 AM EST

Merrill Lynch Rates 5 Dividend Aristocrat Stocks as Top 2018 Buys

While not the most exciting companies in the world, these five Dividend Aristocrats will certainly hold up much better than…

Lee Jackson | Jan 29, 2018 at 9:15 AM EST

Top Analyst Upgrades and Downgrades: AbbVie, Apple, Exact Sciences, Freeport-McMoran, Laboratory Corp, Splunk and More

The top analyst upgrades, downgrades and other research calls from Monday include AbbVie, Apple, Exact Sciences, Freeport-McMoran, Laboratory Corp and…

Chris Lange | Jan 26, 2018 at 4:08 PM EST

Friday’s Biggest Winners and Losers in the S&P 500

Friday was a positive day for the U.S. markets. We are currently in the midst of the fourth quarter earnings…

Chris Lange | Jan 26, 2018 at 8:50 AM EST

AbbVie’s Q4 Boosted by Strong Segment Results

AbbVie reported better-than-expected fourth-quarter financial results before the markets opened on Friday.

Chris Lange | Jan 25, 2018 at 10:10 AM EST

Major Pharma Short Interest Keeps Climbing

The January 12 short interest data have been compared with the previous figures, and short interest in most of these…

Lee Jackson | Jan 25, 2018 at 10:00 AM EST

SunTrust Bullish on Blue Chip Large-Cap Pharmaceuticals: 4 to Buy Now

With the market trading at very extended valuations, and the S&P 500 on the longest streak ever without a 5%…

1 … 20 21 22 23 24 … 39

AbbVie : ABBV

All AbbVie Articles

Thursday’s Biggest Winners and Losers in the S&P 500

AbbVie Slides on Weak Midstage Results

Jefferies Adds Red-Hot Retail Stock to Franchise Picks List

Major Pharma Sees Big Drop in Short Interest

Short Sellers Hike Bets in Major Pharma

Jefferies Has 5 Stocks to Buy That Should Raise Dividends and Earnings

13 Fresh Dividend Hikes and Stock Buybacks Too Big to Ignore

AbbVie Delivers on Promise of Higher Dividend and Stronger Stock Buybacks

Short Sellers Can’t Make Up Their Minds on Major Pharma

Merrill Lynch Rates 5 Dividend Aristocrat Stocks as Top 2018 Buys

Top Analyst Upgrades and Downgrades: AbbVie, Apple, Exact Sciences, Freeport-McMoran, Laboratory Corp, Splunk and More

Friday’s Biggest Winners and Losers in the S&P 500

AbbVie’s Q4 Boosted by Strong Segment Results

Major Pharma Short Interest Keeps Climbing

SunTrust Bullish on Blue Chip Large-Cap Pharmaceuticals: 4 to Buy Now

Why Affluent Couples Are Draining the Higher-Earning Spouse’s 401(k) First to Avoid the Widow’s Tax Penalty

Crypto Crash Today: Why Bitcoin, Ethereum, XRP, and Solana Are All Down Double Digits

Billionaire Bill Ackman’s Pershing Square Exits Universal Music After Failed Takeover Bids, Stock Slumps 7%

Why Affluent Couples Are Draining the Higher-Earning Spouse's 401(k) First to Avoid the Widow's Tax Penalty

Middle-Class Fortysomethings Have a $427,000 Problem and a Shrinking Window to Fix It

Why Affluent Couples Are Draining the Higher-Earning Spouse’s 401(k) First to Avoid the Widow’s Tax Penalty

Crypto Crash Today: Why Bitcoin, Ethereum, XRP, and Solana Are All Down Double Digits

AbbVie : ABBV

All AbbVie Articles

Thursday’s Biggest Winners and Losers in the S&P 500

AbbVie Slides on Weak Midstage Results

Jefferies Adds Red-Hot Retail Stock to Franchise Picks List

Major Pharma Sees Big Drop in Short Interest

Short Sellers Hike Bets in Major Pharma

Jefferies Has 5 Stocks to Buy That Should Raise Dividends and Earnings

13 Fresh Dividend Hikes and Stock Buybacks Too Big to Ignore

AbbVie Delivers on Promise of Higher Dividend and Stronger Stock Buybacks

Short Sellers Can’t Make Up Their Minds on Major Pharma

Merrill Lynch Rates 5 Dividend Aristocrat Stocks as Top 2018 Buys

Top Analyst Upgrades and Downgrades: AbbVie, Apple, Exact Sciences, Freeport-McMoran, Laboratory Corp, Splunk and More

Friday’s Biggest Winners and Losers in the S&P 500

AbbVie’s Q4 Boosted by Strong Segment Results

Major Pharma Short Interest Keeps Climbing

SunTrust Bullish on Blue Chip Large-Cap Pharmaceuticals: 4 to Buy Now

Why Affluent Couples Are Draining the Higher-Earning Spouse’s 401(k) First to Avoid the Widow’s Tax Penalty

Crypto Crash Today: Why Bitcoin, Ethereum, XRP, and Solana Are All Down Double Digits

Billionaire Bill Ackman’s Pershing Square Exits Universal Music After Failed Takeover Bids, Stock Slumps 7%

Featured Reads

Why Affluent Couples Are Draining the Higher-Earning Spouse's 401(k) First to Avoid the Widow's Tax Penalty

Middle-Class Fortysomethings Have a $427,000 Problem and a Shrinking Window to Fix It